The SWI/SNF tumor suppressor complex: Regulation of promoter nucleosomes and beyond

Nucleus (United States)

Volumn 4, Issue 5, 2013, Pages 374-378

  Lu, Ping ^a,b,c   Roberts, Charles W M ^a,b,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

BAF47; Brg1; Chromatin remodeling; Epigenetic instability; Nucleosome; SMARCA4; SMARCB1; SNF5; SWI SNF

Indexed keywords

BARRIER TO AUTOINTEGRATION FACTOR; BRG1 PROTEIN; HISTONE; PROTEIN SWI; TRANSCRIPTION FACTOR SNF; TUMOR SUPPRESSOR PROTEIN;

ALLELE; ARTICLE; CHROMATIN STRUCTURE; CHROMOSOMAL INSTABILITY; DOWNSTREAM PROCESSING; ENVIRONMENTAL STRESS; EPIGENETIC REPRESSION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; NUCLEOSOME; PROMOTER REGION; RHABDOID TUMOR; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION SITE; ANIMAL; BAF47; BRG1; CHROMATIN ASSEMBLY AND DISASSEMBLY; EPIGENETIC INSTABILITY; GENETICS; METABOLISM; MUTATION; NEOPLASM; REVIEW; SMARCA4; SMARCB1; SNF5; SWI/SNF;

EUKARYOTA; MAMMALIA;

BAF47; BRG1; CHROMATIN REMODELING; EPIGENETIC INSTABILITY; NUCLEOSOME; SMARCA4; SMARCB1; SNF5; SWI/SNF;

ANIMALS; HUMANS; MUTATION; NEOPLASMS; NUCLEOSOMES; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 84887471050     PISSN: 19491034     EISSN: 19491042     Source Type: Journal    
DOI: 10.4161/nucl.26654     Document Type: Article

References (48)

1. Woodcock CL, Ghosh RP. Chromatin higher-order structure and dynamics. Cold Spring Harb Perspect Biol 2010; 2:a000596. PMID:20452954; http://dx.doi.org/10.1101/cshperspect.a000596.
2. Jiang C, Pugh BF. Nucleosome positioning and gene regulation: advances through genomics. Nat Rev Genet 2009; 10:161-72. PMID:19204718; http://dx.doi.org/10.1038/nrg2522.
3. Struhl K, Segal E. Determinants of nucleosome positioning. Nat Struct Mol Biol 2013; 20:267-73. PMID:23463311; http://dx.doi.org/10.1038/nsmb.2506.
4. Zhang Z, Wippo CJ, Wal M, Ward E, Korber P, Pugh BF. A packing mechanism for nucleosome organization reconstituted across a eukaryotic genome. Science 2011; 332:977-80. PMID:21596991; http://dx.doi.org/10.1126/science.1200508.
5. Cairns BR. The logic of chromatin architecture and remodelling at promoters. Nature 2009; 461:193-8. PMID:19741699; http://dx.doi.org/10.1038/nature08450.
6. Wilson BG, Roberts CW. SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 2011; 11:481-92. PMID:21654818; http://dx.doi.org/10.1038/nrc3068.
7. Whitehouse I, Flaus A, Cairns BR, White MF, Workman JL, Owen-Hughes T. Nucleosome mobilization catalysed by the yeast SWI/SNF complex. Nature 1999; 400:784-7. PMID:10466730; http://dx.doi.org/10.1038/23506.
8. Kassabov SR, Zhang B, Persinger J, Bartholomew B. SWI/SNF unwraps, slides, and rewraps the nucleosome. Mol Cell 2003; 11:391-403. PMID:12620227; http://dx.doi.org/10.1016/S1097-2765(03)00039-X
9. Phelan ML, Schnitzler GR, Kingston RE. Octamer transfer and creation of stably remodeled nucleosomes by human SWI-SNF and its isolated ATPases. Mol Cell Biol 2000; 20:6380-9. PMID:10938115; http://dx.doi.org/10.1128/MCB.20.17.6380-6389.2000.
10. Reisman D, Glaros S, Thompson EA. The SWI/SNF complex and cancer. Oncogene 2009; 28:1653-68. PMID:19234488; http://dx.doi.org/10.1038/onc.2009.4.
11. Ho L, Crabtree GR. Chromatin remodelling during development. Nature 2010; 463:474-84. PMID:20110991; http://dx.doi.org/10.1038/nature08911.
12. Versteege I, Sévenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R, Aurias A, Delattre O. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 1998; 394:203-6. PMID:9671307; http://dx.doi.org/10.1038/28212.
13. Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 1999; 59:74-9. PMID:9892189.
14. Roberts CW, Leroux MM, Fleming MD, Orkin SH. Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. Cancer Cell 2002; 2:415-25. PMID:12450796; http://dx.doi.org/10.1016/S1535-6108(02)00185-X
15. Roberts CW, Galusha SA, McMenamin ME, Fletcher CD, Orkin SH. Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. Proc Natl Acad Sci U S A 2000; 97:13796-800. PMID:11095756; http://dx.doi.org/10.1073/pnas.250492697.
16. Guidi CJ, Sands AT, Zambrowicz BP, Turner TK, Demers DA, Webster W, Smith TW, Imbalzano AN, Jones SN. Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice. Mol Cell Biol 2001; 21:3598-603. PMID:11313485; http://dx.doi.org/10.1128/MCB.21.10.3598-3603.2001.
17. Klochendler-Yeivin A, Fiette L, Barra J, Muchardt C, Babinet C, Yaniv M. The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep 2000; 1:500-6. PMID:11263494.
18. Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, Crabtree GR. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nat Genet 2013; 45:592-601. PMID:23644491; http://dx.doi.org/10.1038/ng.2628.
19. Dykhuizen EC, Hargreaves DC, Miller EL, Cui K, Korshunov A, Kool M, Pfister S, Cho YJ, Zhao K, Crabtree GR. BAF complexes facilitate decatenation of DNA by topoisomerase IIα. Nature 2013; 497:624-7. PMID:23698369; http://dx.doi.org/10.1038/nature12146.
20. Park JH, Park EJ, Lee HS, Kim SJ, Hur SK, Imbalzano AN, Kwon J. Mammalian SWI/SNF complexes facilitate DNA double-strand break repair by promoting gamma-H2AX induction. EMBO J 2006; 25:3986-97. PMID:16932743; http://dx.doi.org/10.1038/sj.emboj.7601291.
21. Zhao Q, Wang QE, Ray A, Wani G, Han C, Milum K, Wani AA. Modulation of nucleotide excision repair by mammalian SWI/SNF chromatin-remodeling complex. J Biol Chem 2009; 284:30424-32. PMID:19740755; http://dx.doi.org/10.1074/jbc. M109.044982.
22. Lee RS, Stewart C, Carter SL, Ambrogio L, Cibulskis K, Sougnez C, Lawrence MS, Auclair D, Mora J, Golub TR, et al. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. J Clin Invest 2012; 122:2983-8. PMID:22797305; http://dx.doi.org/10.1172/JCI64400.
23. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis 2010; 31:27-36. PMID:19752007; http://dx.doi.org/10.1093/carcin/bgp220
24. McKenna ES, Roberts CW. Epigenetics and cancer without genomic instability. Cell Cycle 2009; 8:23-6. PMID:19098432; http://dx.doi.org/10.4161/cc.8.1.7290.
25. Lee RS, Roberts CW. Rhabdoid tumors: an initial clue to the role of chromatin remodeling in cancer. Brain Pathol 2013; 23:200-5. PMID:23432645; http://dx.doi.org/10.1111/bpa.12021.
26. Tolstorukov MY, Sansam CG, Lu P, Koellhoffer EC, Helming KC, Alver BH, Tillman EJ, Evans JA, Wilson BG, Park PJ, et al. Swi/Snf chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promoters. Proc Natl Acad Sci U S A 2013; 110:10165-70. PMID:23723349; http://dx.doi.org/10.1073/pnas.1302209110.
27. Batta K, Zhang Z, Yen K, Goffman DB, Pugh BF. Genome-wide function of H2B ubiquitylation in promoter and genic regions. Genes Dev 2011; 25:2254-65. PMID:22056671; http://dx.doi.org/10.1101/gad.177238.111.
28. Gkikopoulos T, Schofield P, Singh V, Pinskaya M, Mellor J, Smolle M, Workman JL, Barton GJ, Owen-Hughes T. A role for Snf2-related nucleosomespacing enzymes in genome-wide nucleosome organization. Science 2011; 333:1758-60. PMID:21940898; http://dx.doi.org/10.1126/science.1206097.
29. Pointner J, Persson J, Prasad P, Norman-Axelsson U, Strålfors A, Khorosjutina O, Krietenstein N, Svensson JP, Ekwall K, Korber P. CHD1 remodelers regulate nucleosome spacing in vitro and align nucleosomal arrays over gene coding regions in S. pombe. EMBO J 2012; 31:4388-403. PMID:23103765; http://dx.doi.org/10.1038/emboj.2012.289.
30. Hu G, Schones DE, Cui K, Ybarra R, Northrup D, Tang Q, Gattinoni L, Restifo NP, Huang S, Zhao K. Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1. Genome Res 2011; 21:1650-8. PMID:21795385; http://dx.doi.org/10.1101/gr.121145.111.
31. Yen K, Vinayachandran V, Batta K, Koerber RT, Pugh BF. Genome-wide nucleosome specificity and directionality of chromatin remodelers. Cell 2012; 149:1461-73. PMID:22726434; http://dx.doi.org/10.1016/j.cell.2012.04.036.
32. Ho L, Jothi R, Ronan JL, Cui K, Zhao K, Crabtree GR. An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proc Natl Acad Sci U S A 2009; 106:5187-91. PMID:19279218; http://dx.doi.org/10.1073/pnas.0812888106.
33. Jin C, Zang C, Wei G, Cui K, Peng W, Zhao K, Felsenfeld G. H3.3/H2A.Z double variant-containing nucleosomes mark 'nucleosome-free regions' of active promoters and other regulatory regions. Nat Genet 2009; 41:941-5. PMID:19633671; http://dx.doi.org/10.1038/ng.409.
34. Weiner A, Hughes A, Yassour M, Rando OJ, Friedman N. High-resolution nucleosome mapping reveals transcription-dependent promoter packaging. Genome Res 2010; 20:90-100. PMID:19846608; http://dx.doi.org/10.1101/gr.098509.109.
35. Wyrick JJ, Holstege FC, Jennings EG, Causton HC, Shore D, Grunstein M, Lander ES, Young RA. Chromosomal landscape of nucleosome-dependent gene expression and silencing in yeast. Nature 1999; 402:418-21. PMID:10586882; http://dx.doi.org/10.1038/46567.
36. Celona B, Weiner A, Di Felice F, Mancuso FM, Cesarini E, Rossi RL, Gregory L, Baban D, Rossetti G, Grianti P, et al. Substantial histone reduction modulates genomewide nucleosomal occupancy and global transcriptional output. PLoS Biol 2011; 9:e1001086. PMID:21738444; http://dx.doi.org/10.1371/journal.pbio.1001086.
37. Teif VB, Vainshtein Y, Caudron-Herger M, Mallm JP, Marth C, Höfer T, Rippe K. Genome-wide nucleosome positioning during embryonic stem cell development. Nat Struct Mol Biol 2012; 19:1185-92. PMID:23085715; http://dx.doi.org/10.1038/nsmb.2419.
38. Petesch SJ, Lis JT. Overcoming the nucleosome barrier during transcript elongation. Trends Genet 2012; 28:285-94. PMID:22465610; http://dx.doi.org/10.1016/j.tig.2012.02.005.
39. Lenhard B, Sandelin A, Carninci P. Metazoan promoters: emerging characteristics and insights into transcriptional regulation. Nat Rev Genet 2012; 13:233-45. PMID:22392219.
40. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007; 39:311-8. PMID:17277777; http://dx.doi.org/10.1038/ng1966.
41. Whitehouse I, Rando OJ, Delrow J, Tsukiyama T. Chromatin remodelling at promoters suppresses antisense transcription. Nature 2007; 450:1031-5. PMID:18075583; http://dx.doi.org/10.1038/nature06391.
42. Kaplan CD, Laprade L, Winston F. Transcription elongation factors repress transcription initiation from cryptic sites. Science 2003; 301:1096-9. PMID:12934008; http://dx.doi.org/10.1126/science.1087374.
43. Guidos C. "Cryptic" Notch1 messages induce T-ALL. Blood 2010; 116:5436-8. PMID:21163932; http://dx.doi.org/10.1182/blood-2010-10-311712.
44. Batsché E, Yaniv M, Muchardt C. The human SWI/SNF subunit Brm is a regulator of alternative splicing. Nat Struct Mol Biol 2006; 13:22-9. PMID:16341228; http://dx.doi.org/10.1038/nsmb1030.
45. David CJ, Manley JL. Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev 2010; 24:2343-64. PMID:21041405; http://dx.doi.org/10.1101/gad.1973010.
46. Tirosh I, Barkai N. Two strategies for gene regulation by promoter nucleosomes. Genome Res 2008; 18:1084-91. PMID:18448704; http://dx.doi.org/10.1101/gr.076059.108.
47. Raser JM, O'Shea EK. Control of stochasticity in eukaryotic gene expression. Science 2004; 304:1811-4. PMID:15166317; http://dx.doi.org/10.1126/science.1098641.
48. Timp W, Feinberg AP. Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat Rev Cancer 2013; 13:497-510. PMID:23760024; http://dx.doi.org/10.1038/nrc3486